Effects of patient controlled analgesia hydromorphone during acute painful episodes in adolescents with sickle cell disease: A pilot study

Published

Book Section

© 2009 Nova Science Publishers, Inc. All rights reserved. The use of hydromorphone is increasing but little is known about its effects during painful episodes in adolescents with sickle cell disease. This pilot study examined the intensity, location, and quality of pain and evaluated the amount of relief and side effects from PCA hydromorphone during acute painful episodes in five adolescents with sickle cell disease. Data suggest that hydromorphone may provide a better alternative than morphine, the most commonly prescribed opioid in patients with sickle cell disease. Hydromorphone may provide improved pain control and recovery from acute painful episodes in patients with sickle cell disease.

Duke Authors

Cited Authors

  • Jacob, E; Hockenberry, M; Mueller, BU

Published Date

  • October 1, 2008

Book Title

  • Pain in Children and Youth

Start / End Page

  • 115 - 122

International Standard Book Number 13 (ISBN-13)

  • 9781604569513

Citation Source

  • Scopus